Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|1|30-47

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.1, 2013-01, pp. : 30-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

By Shimoni Avichai   Volchek Yulia   Koren-Michowitz Maya   Varda-Bloom Nira   Somech Raz   Shem-Tov Noga   Yerushalmi Ronit   Nagler Arnon  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 863-871

Blackwell Publishing

Access to resources Recommend Favorite

Antiangiogenic Therapy in Acute Myelogenous Leukemia: Targeting of Vascular Endothelial Growth Factor and Interleukin 8 as Possible Antileukemic Strategies

By  

Current Cancer Drug Targets, Vol. 5, Iss. 4, 2005-06 ,pp. : 229-248

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention and Early Treatment of Opportunistic Viral Infections in Patients With Leukemia and Allogeneic Stem Cell Transplantation Recipients

By Angarone Michael   Ison Michael G.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 191-201

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Haploidentical Allogeneic Haematopoietic Stem Cell Transplantation as Salvage Therapy for Engraftment Failure after Unrelated and Autologous Stem Cell Transplantation: a Case Report and Review of the Literature

By Tan Y-M   Fu H-R   Luo Y   Shi J-M   Ye X-J   Zheng Y-L   Xiao H-W   Hu Y-X   Huang H  

The Journal of International Medical Research, Vol. 39, Iss. 3, 2011-05 ,pp. : 950-959

Field House Publishing

Access to resources Recommend Favorite

Innovative Cell Therapy in the Treatment of Serious Adverse Events Related to Both Chemo-Radiotherapy Protocol and Acute Myeloid Leukemia Syndrome: The Infusion of Mesenchymal Stem Cells Post-Treatment Reduces Hematopoietic Toxicity and Promotes Hematopoietic Reconstitution

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 9, 2013-10 ,pp. : 842-848

Bentham Science Publishers

Access to resources Recommend Favorite